Trident Lifeline Limited
Trident Lifeline Limited is an Indian listed company in the Pharmaceuticals & Biotechnology industry (Healthcare sector), traded under BSE: 543616 (ISIN INE0MKA01014).
It has a market capitalisation of ₹480 crore, a last close of ₹402.00 on 2026-10-19, a one-year return of 30.2%.
Valuation: a price-to-earnings ratio of 22.21x, a price-to-book ratio of 4.96x.
Profitability: return on equity of 24.0%, return on capital employed of 24.9%, an operating margin of 22.6%.
Growth: sales growth of 59.7% a year over three years, net profit growth of 47.5% a year over three years.
Balance sheet and ownership: debt-to-equity of 0.75x, promoter holding of 62.5%.
| Metric | Value |
|---|---|
| Market capitalisation | 480 |
| Last close | ₹402.00 |
| P/E (TTM) | 22.21x |
| P/B | 4.96x |
| ROE (FY) | 24.0% |
| ROCE (FY) | 24.9% |
| Operating margin (TTM) | 22.6% |
| Sales growth, 3-year CAGR | 59.7% |
| Profit growth, 3-year CAGR | 47.5% |
| Debt / equity | 0.75x |
| Promoter holding | 62.5% |
| 1-year return | 30.2% |
Loading the live page with the price chart, financial history, shareholding and recent filings. Data is end-of-day and rebuilt nightly; nothing here is investment advice. Financial statements · What each metric means